Low levels of adiponectin predict worsening of arterial morphology and function

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages

  Störk, Stefan ^c,d   Bots, Michiel L ^c   Angerer, Peter ^b   von Schacky, Clemens ^b   Grobbee, Diederick E ^c   Angermann, Christiane E ^a   Seufert, Jochen ^d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adiponectin; Atherosclerosis; Carotid artery; Distensibility; Intima media thickness; Risk factors

Indexed keywords

ADIPONECTIN;

ADULT; ADVERSE OUTCOME; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MORPHOLOGY; OPTICAL RESOLUTION; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ADIPONECTIN; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; ELASTICITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; TUNICA INTIMA; TUNICA MEDIA;

EID: 34848867157     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.11.044     Document Type: Article

References (37)

1. Ukkola O., and Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities?. J Mol Med 80 (2002) 696-702
2. Maeda K., Okubo K., Shimomura I., et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 221 (1996) 286-289
3. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
4. Fernandez-Real J.M., Lopez-Bermejo A., Casamitjana R., and Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab 88 (2003) 2714-2718
5. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
6. Tschritter O., Fritsche A., Thamer C., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52 (2003) 239-243
7. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
8. Matsuda M., Shimomura I., Sata M., et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 277 (2002) 37487-37491
9. Yamamoto Y., Hirose H., Saito I., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 103 (2002) 137-142
10. Esposito K., Pontillo A., Di Palo C., et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289 (2003) 1799-1804
11. Shetty G.K., Economides P.A., Horton E.S., Mantzoros C.S., and Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27 (2004) 2450-2457
12. Iwashima Y., Katsuya T., Ishikawa K., et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43 (2004) 1318-1323
13. Tan K.C.B., Xu A., Chow W.S., et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89 (2004) 765-769
14. Pischon T., Girman C.J., Hotamisligil G.S., et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
15. Schulze M.B., Shai I., Rimm E.B., et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54 (2005) 534-539
16. Chen M.P., Tsai J.C., Chung F.M., et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 821-826
17. Angerer P., Störk S., Kothny W., Schmitt P., and von Schacky C. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomized, controlled trial. Arterioscler Thromb Vasc Biol 21 (2001) 262-268
18. Angerer P., Kothny W., Störk S., and von Schacky C. Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial. J Am Coll Cardiol 36 (2000) 1789-1796
19. Angerer P., Störk S., and von Schacky C. Influence of 17beta-oestradiol on blood pressure of postmenopausal women at high vascular risk. J Hypertens 19 (2001) 2135-2142
20. Matsubara M., Maruoka S., and Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 147 (2002) 173-180
21. Engeli S., Feldpausch M., Gorzelniak K., et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52 (2003) 942-947
22. Krakoff J., Funahashi T., Stehouwer C.D., et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26 (2003) 1745-1751
23. Gavrila A., Chan J.L., Yiannakouris N., et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88 (2003) 4823-4831
24. Shamsuzzaman A.S., Winnicki M., Wolk R., et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109 (2004) 2181-2185
25. Maahs D.M., Ogden L.G., Kinney G.L., et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111 (2005) 747-753
26. Spranger J., Kroke A., Mohlig M., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361 (2003) 226-228
27. Bots M.L., Dijk J.M., Oren A., and Grobbee D.E. Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens 20 (2002) 2317-2325
28. Safar M.E., Levy B.I., and Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107 (2003) 2864-2869
29. Störk S., van den Beld A.W., von Schacky C., et al. Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study. Circulation 110 (2004) 344-348
30. Dijk J.M., Algra A., van der Graaf Y., Grobbee D.E., and Bots M.L. Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study. Eur Heart J 26 (2005) 1213-1220
31. de Groot E., Hovingh G.K., Wiegman A., et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109 (2004) III33-III38
32. Bots M.L., Evans G.W., Riley W.A., and Grobbee D.E. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke 34 (2003) 2985-2994
33. Benetos A., Laurent S., Hoeks A.P., Boutouyrie P.H., and Safar M.E. Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arterioscler Thromb 13 (1993) 90-97
34. Liang Y.L., Shiel L.M., Teede H., et al. Effects of blood pressure, smoking, and their interaction on carotid artery structure and function. Hypertension 37 (2001) 6-11
35. Asmar R.G., Girerd X.J., Brahimi M., Safavian A., and Safar M.E. Ambulatory blood pressure measurement, smoking and abnormalities of glucose and lipid metabolism in essential hypertension. J Hypertens 10 (1992) 181-187
36. Safar M.E., Blacher J., Pannier B., et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 39 (2002) 735-738
37. Chambless L.E., Folsom A.R., Davis V., et al. Risk factors for progression of common carotid atherosclerosis: the atherosclerosis risk in communities study, 1987-1998. Am J Epidemiol 155 (2002) 38-47